154 related articles for article (PubMed ID: 10225711)
1. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.
Yajima T; Takaishi H; Kanai T; Iwao Y; Watanabe M; Ishii H; Hibi T
Ther Apher; 1998 May; 2(2):115-9. PubMed ID: 10225711
[TBL] [Abstract][Full Text] [Related]
2. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of leukocytapheresis effect in the treatment of ulcerative colitis].
Sawada K; Ohnishi K; Fukunaga K; Chikano S; Egashira A; Satomi M; Shimoyama T
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):469-74. PubMed ID: 10726487
[TBL] [Abstract][Full Text] [Related]
4. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
Jo Y; Matsumoto T; Mibu R; Iida M
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652
[TBL] [Abstract][Full Text] [Related]
5. Leukocytapheresis is effective in inducing but not in maintaining remission in ulcerative colitis.
Honma T; Sugimura K; Asakura H; Matsuzawa J; Suzuki K; Kobayashi M; Aoyagi Y
J Clin Gastroenterol; 2005; 39(10):886-90. PubMed ID: 16208112
[TBL] [Abstract][Full Text] [Related]
6. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
Nagayama K; Takedatsu H; Mitsuyama K; Yamasaki H; Kuwaki K; Yoshioka S; Kobayashi T; Yamauchi R; Kakuma T; Sata M
Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
[TBL] [Abstract][Full Text] [Related]
8. [Leukocytapheresis for ulcerative colitis].
Fukunaga K; Sawada K; Chikano S; Ohnishi K; Egashira A; Tanaka J; Nagase K; Satomi M; Shimoyama T
Nihon Rinsho; 1999 Nov; 57(11):2496-502. PubMed ID: 10572419
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal leukocyte removal therapy for patients with ulcerative colitis.
Kumagai M; Yamato Y; Maeda K; Nakashima E; Ushijima K; Kimura A
Pediatr Int; 2007 Aug; 49(4):431-6. PubMed ID: 17587263
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
Nakano R; Iwakiri R; Ikeda Y; Kishi T; Tsuruoka N; Shimoda R; Sakata Y; Yamaguchi K; Fujimoto K
J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis.
Kobayashi T; Matsuoka K; Yokoyama Y; Nakamura T; Ino T; Numata T; Shibata H; Aoki H; Matsuno Y; Hibi T
J Gastroenterol; 2018 Mar; 53(3):387-396. PubMed ID: 28597225
[TBL] [Abstract][Full Text] [Related]
12. [Remission by leukocytapheresis for a patient with ulcerative colitis found refractory by conventional drug therapies].
Sawada K; Ohnishi K; Kosaka T; Egashira A; Kinoshita T; Amano K; Yamamura M; Satomi M; Shimoyama T
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):126-33. PubMed ID: 9178970
[TBL] [Abstract][Full Text] [Related]
13. [Leukocytapheresis for ulcerative colitis].
Sawada K; Ohnishi K; Kosaka T; Egashira A; Yamamura M; Satomi M; Shimoyama T
Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):438-42. PubMed ID: 9168498
[TBL] [Abstract][Full Text] [Related]
14. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
Kinugasa T; Akagi Y; Murotani K; Romeo K; Yoshida T; Ryu Y; Shiratuchi I; Shirouzu K
Anticancer Res; 2011 Jul; 31(7):2547-52. PubMed ID: 21873173
[TBL] [Abstract][Full Text] [Related]
15. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.
Sawada K; Muto T; Shimoyama T; Satomi M; Sawada T; Nagawa H; Hiwatashi N; Asakura H; Hibi T
Curr Pharm Des; 2003; 9(4):307-21. PubMed ID: 12570823
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.
Umehara Y; Kudo M; Kawasaki M
World J Gastroenterol; 2008 Sep; 14(34):5316-21. PubMed ID: 18785285
[TBL] [Abstract][Full Text] [Related]
17. Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy.
Fukunaga K; Fukuda Y; Sawada K; Hori K; Matoba Y; Sagayama K; Ohnishi K; Fukui S; Shimoyama T
J Gastroenterol; 2003; 38(7):684-9. PubMed ID: 12898362
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of leukocytapheresis in a pregnant woman with severe active ulcerative colitis.
Okada H; Makidono C; Takenaka R; Hiraoka S; Fujiwara A; Kato J; Kawahara Y; Kawamoto H; Mizuno M; Shiratori Y
Digestion; 2006; 74(1):15-8. PubMed ID: 16940730
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of leukocytapheresis in elderly patients with ulcerative colitis: The impact in steroid-free elderly patients.
Komoto S; Matsuoka K; Kobayashi T; Yokoyama Y; Suzuki Y; Hibi T; Miura S; Hokari R
J Gastroenterol Hepatol; 2018 Aug; 33(8):1485-1491. PubMed ID: 29406567
[TBL] [Abstract][Full Text] [Related]
20. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Kikuyama M; Tanaka T; Kondo K; Tanaka K; Takai K
World J Gastroenterol; 2005 May; 11(20):3085-90. PubMed ID: 15918195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
